ERBB2 and neoplasm: Our findings reveal notable differences in the activities of reversible and irreversible HER2-TKIs and elucidate molecular mechanisms that may explain the effect of irreversible HER2-TKIs in decreasing HER2 protein levels and improving T-Dxd anti-tumor activity.